GB Snowsport manages the country’s elite teams and athletes across twelve Olympic and Paralympic disciplines, with a focus on international competition and high-performance achievement. During the 2025/26 season, ColdZyme® will be part of the federation’s efforts to support its athletes in their pursuit of success.

In a season where GB Snowsport’s athletes push themselves to the limit in pursuit of excellence, cold and flu-like illnesses present a real challenge. Through this partnership, Enzymatica and GB Snowsport aim to help reduce time lost to illness and provide the athletes with the best possible conditions to perform at their peak throughout the season.

Claire Williams, Head of Sport Sciences and Medicine at GB Snowsport, said:

“We’re delighted to have the support of ColdZyme heading into the new season. In a sport where success can be determined by millimetres, cold and flu-like illnesses can have a significant impact on both training and competition. Working with ColdZyme allows us to ensure our athletes are supported in the best possible way ahead of one of the most significant seasons in modern British snowsport history.”

Charlotte Hodgkins-Byrne, Director of Strategic Partnerships at Enzymatica, said:

“We are very pleased to be partnering with GB Snowsport throughout the 2025/26 season. Clinical studies have shown that ColdZyme can shorten the duration of virus-related respiratory infections, reduce symptoms, and decrease viral load. Supporting these athletes at such a pivotal – and exciting – stage is something we are extremely proud of, and we look forward to following their journey towards the Milano Cortina 2026 Winter Olympics and Paralympics.”